advertisement
Abstract #60084 Published in IGR 16-4
A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface
Tailor R; Batra R; Mohamed SSeminars in Ophthalmology 2014; 0: 1-7
BACKGROUND: Preserved anti-glaucoma drops cause ocular surface disease (OSD), which is increasingly being recognized as a likely cause of trabeculectomy failure. AIM: To determine the routine pre-trabeculectomy management of the ocular surface by glaucoma specialists. METHODS: A questionnaire consisting of 11 questions was posted to 146 UK glaucoma specialists. RESULTS: The first-time response rate was 43.8%. Regarding routine pre-operative management, 40.6% of specialists use preservative-free drops, 29.7% commence a drop holiday, and 53% advise lid hygiene. 42.1% prescribe lubricants, 50% prescribe topical steroids, 7.8% topical NSAIDs, and 34.4% systemic tetracyclines. 84.4% of specialists change their routine management if OSD is present. Pre-operative optimization of the ocular surface is viewed "necessary" by 48.4% and "beneficial" by 85.9%. CONCLUSION: A wide variation exists in the routine pre-operative management of the ocular surface. Research to determine the impact of different pre-operative interventions upon trabeculectomy outcomes is required.
Department of Ophthalmology, University Hospitals , Birmingham , UK.
Full articleClassification:
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (Part of: 11 Medical treatment)
2.2 Cornea (Part of: 2 Anatomical structures in glaucoma)
2.1 Conjunctiva (Part of: 2 Anatomical structures in glaucoma)
